CD22 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD22 monoclonal antibodies for investigating CD22's role in various biological processes. CD22 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD22 is a critical receptor expressed on the surface of B cells, playing a significant role in regulating B cell activation and signaling. CD22 is involved in maintaining B cell tolerance and modulating immune responses, making it an important target for therapeutic interventions in autoimmune diseases and B cell malignancies. Understanding CD22 function is essential for developing strategies to manipulate B cell activity in various clinical settings. CD22 research has revealed important insights into B cell development, activation, and regulation. CD22 signaling pathways influence numerous aspects of B cell biology, from antibody production to cellular survival. CD22 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance our understanding of B cell biology and its impact on human health.